Chancellor Reeves Aims for Specific Measures on Living Costs in Forthcoming Financial Plan
Chancellor Rachel Reeves has revealed she is preparing "specific measures to deal with household expense issues" in the forthcoming financial statement.
Speaking to the BBC, she noted that lowering price rises is a joint responsibility of both the government and the central bank.
The UK's inflation rate is forecast to be the most elevated among the G7 advanced economies this year and the following year.
Potential Energy Bill Interventions
Reports indicate the administration could take action to lower energy bills, for example by cutting the present 5% rate of value-added tax charged on energy.
Another approach is to lower some of the government charges currently included in household expenses.
Fiscal Limitations and Expert Predictions
The administration will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these actions.
The expectation from most analysts is that Reeves will have to introduce tax increases or spending cuts in order to meet her declared fiscal targets.
Previously on Thursday, calculations indicated there was a £22 billion shortfall for the chancellor to resolve, which is at the more modest range of expectations.
"There's a shared job between the central bank and the government to further reduce some of the drivers of price increases," the Chancellor told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.
Revenue Pledges and Global Concerns
While much of the attention has been on likely tax increases, the chancellor said the latest figures from the OBR had not changed her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.
She attributed an "unpredictable world" with increasing international and commercial concerns for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."
Global Economic Tensions
Addressing apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests invariably are paramount."
Last week's announcement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are essential for advanced tech production led American leader Donald Trump to suggest an additional 100% tariff on imports from China, raising the prospect of an full-scale trade war between the two largest economies.
The American finance chief called the Chinese decision "economic coercion" and "a global supply chain control attempt."
Questioned on considering the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access."
She said the move was "damaging for the international commerce and creates further headwinds."
"I believe there are fields where we must confront China, but there are also significant prospects to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to get that equilibrium right."
The chancellor also stated she was collaborating with other major economies "regarding our own critical minerals strategy, so that we are less reliant."
NHS Medicine Pricing and Funding
Reeves also acknowledged that the price the NHS spends on pharmaceuticals could increase as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.
A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling operations in the United Kingdom, with several attributing the low prices they are obtaining.
Last month, the government science advisor said the price the health service spends on medicines would must rise to prevent companies and pharmaceutical investment leaving the United Kingdom.
The Chancellor informed media: "It has been observed due to the cost structure, that medical research, new drugs have not been offered in the UK in the manner that they are in other EU nations."
"The objective is to ensure that patients receiving treatment from the NHS are able to receive the top essential treatments in the globe. And so we are examining this situation, and... seeking to secure additional funding into the UK."